Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

Novartis has announced that it will be acquiring Regulus Therapeutics in a deal worth $1.7bn, marking a notable boost to the ...

Transaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a ...

The woman was in severe pain and discomfort, unable to focus on her job, eat, or sleep properly. She was exhausted, but had ...

A nylon maker goes bankrupt, a carbon capture start-up raises money, Germany’s Merck acquires SpringWorks, and more ...

This is the first randomized trial directly comparing pulse-modulated Holmium:YAG laser and thulium fiber laser treatment of kidney stones during ureteroscopy.

For many veterans, dealing with injuries or mental health conditions after service is hard enough. Add in the complexity of ...

The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.

Complete A to Z disease and conditions health guide which provides information on a wide range of diseases and its symptoms, treatment, prevention and cure at thehealthsite.com ...